Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Robotic Surgery Innovation Financing

Minute Insight: Virtual Incision Draws In Another $30m With Its Table-Top Surgical Robot

  • News

Executive Summary

The cash will be used to extend the company’s development runway “well into 2025.”  

You may also be interested in...



Meet MIRA, A Miniaturized, Tabletop Surgical Robot

Virtual Incision’s MIRA robot, if approved, will be the smallest commercially available surgical robot and could transform the accessibility of robotically assisted surgery worldwide.

Seeing The Wood From The Shrubs: Azalea Begins Tests Of Its Smart Contact Lens

The Belgian start-up is developing a scleral contact lens with an inbuilt LCD screen capable of filtering light – offering a non-surgical solution to a variety of ophthalmic conditions.

Octave Biosciences Takes It Up Another Semitone With Michael J Fox Foundation Grant

The diagnostics company has secured $10m from the foundation to develop a biomarker test for Parkinson’s disease.

Table

View full table

Topics

Tags:
Robotic Surgery Innovation Financing
Latest Headlines

EU Lists Its First Reference Laboratories For High-Risk IVDs Falling Into Class D

German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023

Mosie Baby First To Win FDA Clearance For At-Home Artificial Insemination Kit

“We’re A Pain-Management Company.” Nevro Adds SI Joint Surgery To SCS Business

See All
UsernamePublicRestriction

Register

MT148290

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By